£
Donate
Search
Donate

We're here for you if you want to talk

0808 2080 888

[email protected]

Our campaigns

We work with healthcare professionals, parliament and our blood cancer community to help raise awareness of blood cancer and bring us closer to the day where no one dies of blood cancer or its treatment.

A close up of a black girl looking straight into the camera, light shining on her face with the background surrounded in shadows.

UK Blood Cancer Action Plan

Our Action Plan reveals shocking data about blood cancer survival in the UK. We need healthcare professionals and those affected by blood cancer to turn our set of recommendations into a reality.

Yvonne, case study

Raise blood cancer's profile

Despite being the fifth most common cancer and the third biggest cancer killer in the UK, blood cancer doesn’t receive the public profile of the other four common cancers. We're determined to change that.

A collage of a group of eight people, all smiling, as part of the #SayBloodCancer campaign.

Blood Cancer Awareness Month

Every September, we campaign during Blood Cancer Awareness Month to raise awareness of blood cancer.

All Party Parliamentary Group on Blood Cancer

The APPGBC raises awareness and promotes the needs of blood cancer patients with parliamentarians, government, NHS, and charity stakeholders.

What is the APPGBC?

Blood Cancer Awareness Month

Blood Cancer Awareness Month is held every September to raise the profile of blood cancer, which doesn't get the attention of other cancers

Raise the profile of blood cancer

Find out how Blood Cancer UK is raising the profile of blood cancer.

The All Party Parliamentary Group on Blood Cancer (APPGBC)

Blood Cancer UK run the secretariat for the All-Party Parliamentary Group on Blood Cancer on behalf of the Chair, Henry Smith MP (Con, Crawley) and the Vice Chair, Colleen Fletcher (MP, Lab Coventry North East).

UK Blood Cancer Action Plan

Our Action Plan reveals shocking data about blood cancer survival in the UK. We need healthcare professionals and those affected by blood cancer to turn our set of recommendations into a reality.